نتایج جستجو برای: hbv vaccine non

تعداد نتایج: 1426445  

Journal: :Memorias do Instituto Oswaldo Cruz 2011
Ana Luiza N Junqueira Viviane R Tavares Regina M B Martins Kamilla V Frauzino Agabo M da Costa e Silva Izolina M X Rodrigues Ruth Minamisava Sheila A Teles

Recently, it was suggested that maternal hepatitis B surface antigen antibodies (anti-HBs) acquired transplacentally could play a negative role in newborn infants' immune response to the hepatitis B vaccine. We compared the hepatitis B virus (HBV) vaccine response in infants born to mothers previously vaccinated against HBV (n = 91) to infants born to mothers who were not previously vaccinated ...

Journal: :Central European journal of public health 2005
J Beran P Dedek V Stepánová M Spliio O Pozler

Patients with autoimmune hepatitis (AIH) are a group at risk of disease exacerbation or relapse of the underlying disease should they fall ill with infectious hepatitis A (HAV) or B (HBV). Therefore, it seems appropriate to protect this group of persons against HAV and HBV disease by vaccination. An open study evaluated the safety, reactogenicity and immunogenicity of a combined HAV and HBV vac...

2014
Thomas H. King Charles B. Kemmler Zhimin Guo Derrick Mann Yingnian Lu Claire Coeshott Adam J. Gehring Antonio Bertoletti Zi Z. Ho William Delaney Anuj Gaggar G. Mani Subramanian John G. McHutchison Shikha Shrivastava Yu-Jin L. Lee Shyamasundaran Kottilil Donald Bellgrau Timothy Rodell David Apelian

Chronic hepatitis B infection (CHB) is characterized by sub-optimal T cell responses to viral antigens. A therapeutic vaccine capable of restoring these immune responses could potentially improve HBsAg seroconversion rates in the setting of direct acting antiviral therapies. A yeast-based immunotherapy (Tarmogen) platform was used to make a vaccine candidate expressing hepatitis B virus (HBV) X...

2011
Emeka B. Kesieme Kenechi Uwakwe Eshiobo Irekpita Andrew Dongo Kefas John Bwala Bamidele J. Alegbeleye

Background. Hepatitis B virus (HBV) infection is a well recognised occupational health hazard preventable by vaccination. Objectives. To determine the knowledge of operating room personnel (ORP) in Nigeria about the Hepatitis B vaccine, their perception of Hepatitis B vaccination and vaccination status against HBV. Methods. Four university hospitals were selected by simple random sampling. A st...

Journal: :Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 2017
Tarcila Maria Bonfim Ferreira Tácio Giordano Santana Guimarães Andrea Martins Melo Fontenele Natalino Salgado Adalgisa de Souza Paiva Ferreira Alessandra Porto de Macedo Costa

INTRODUCTION Vaccination is the most effective tool in preventing transmission of Hepatitis B Virus (HBV). The patient with chronic kidney disease (CKD) on dialysis appear to be at greater risk of becoming infected with this virus and does not show the same vaccine response when compared to patients without uremia. OBJECTIVES To evaluate the results related to the HBV vaccine and identify fac...

Journal: :The New England journal of medicine 1984
S D Kreider W R Lange

Many Vaccine Information Statements are available in Spanish and other languages. See www.immunize.org/vis. 1 What is hepatitis B? Hepatitis B is a serious disease that affects the liver. It is caused by the hepatitis B virus (HBV). HBV can cause: Acute (short-term) illness. This can lead to: • loss of appetite • diarrhea and vomiting • tiredness • jaundice (yellow skin or eyes) • pain in muscl...

2012
Mohammad Hossein Somi Babak Hajipour

Hepatitis B virus (HBV) infection is a serious global health problem.The prevalence of viral hepatitis is higher in dialysis patients than in the general population because of the opportunity for exposure during the dialysis procedure. Immunization is the most effective way to prevent transmission of hepatitis B virus (HBV) and hence the development of acute or chronic hepatitis B. It is well e...

Journal: :Vaccine 2007
Mongkol Lao-araya Thanyawee Puthanakit Linda Aurpibul Thira Sirisanthana Virat Sirisanthana

Despite a history of hepatitis B virus (HBV) vaccination prior to highly active antiretroviral therapy (HAART), most of HIV-infected children do not have protective antibody to HBV infection. The efficacy of an additional booster dose in children with immune recovery on HAART remains unknown. This study was conducted to determine the response rate of HBV antibody after re-vaccination in HIV-inf...

Journal: :American journal of epidemiology 2011
Michael L Landrum Katherine Huppler Hullsiek Helen M Chun Nancy F Crum-Cianflone Anuradha Ganesan Amy C Weintrob R Vincent Barthel Robert J O'Connell Brian K Agan

To assess associations between the timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and vaccine effectiveness, US Military HIV Natural History Study cohort participants without HBV infection at the time of HIV diagnosis were grouped by vaccination status, retrospectively followed from HIV diagnosis for incident HBV infection, and compared u...

Journal: :Frontiers in bioscience 2010
Baruch S Blumberg

Primary cancer of the liver (hepatocellular carcinoma, HCC) is one of the most common cancers worldwide; HBV is the major cause of HCC. A vaccine that protects against HBV infection was invented in 1969 and is now one of the most commonly used vaccines. National vaccination programs have dramatically reduced the prevalence of HBV infection and carriers, with a concomitant decrease in the incide...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید